Publication | Closed Access

Determination of the time for maximal response to neoadjuvant hormone therapy for prostate cancer using magnetic resonance with spectroscopy (MRSI) and dynamic contrast enhancement (DCEMR)

UrologyEngineeringMedical ImagingMagnetic Resonance SpectroscopyMedicineBiomedical ImagingMagnetic ResonanceProstatic DiseaseContrast AgentMri-guided Radiation TherapyOncologyDynamic Contrast EnhancementNuclear MedicineMagnetic Resonance ImagingRadiology